Quick Answer
Lipocine Inc. reported Long-Term Debt of $2.26 million for fiscal year 2020.
Lipocine Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2020 | $2.26M | -40.8% |
| 2019 | $3.81M | -44.9% |
| 2018 | $6.93M | — |
| 2017 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| March 31, 2021 | $1.44M | -69.2% | -36.1% |
| December 31, 2020 | $2.26M | -40.8% | -28.4% |
| September 30, 2020 | $3.15M | -31.5% | -21.3% |
| June 30, 2020 | $4.00M | -25.7% | -14.6% |
| March 31, 2020 | $4.69M | -23.9% | +22.9% |
| December 31, 2019 | $3.81M | -44.9% | -17.1% |
| September 30, 2019 | $4.60M | -41.4% | -14.5% |
| June 30, 2019 | $5.38M | -37.3% | -12.6% |
- Lipocine Inc. showed a decrease of -40.8% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Lipocine Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 9, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: